Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

eUpdate – Acute Lymphoblastic Leukaemia Treatment Recommendations

ESMO Clinical Practice Guideline interim update on the use of targeted therapy in acute lymphoblastic leukaemia

Ann Oncol. 2024;35(1):15-28.

D. Hoelzer, R. Bassan, N. Boissel, et al., on behalf of the ESMO Guidelines Committee

  • This ESMO Clinical Practice Guideline update provides key recommendations for managing acute lymphoblastic leukaemia.
  • The update covers recent developments in the use of targeted therapies.
  • Algorithms for the management of newly diagnosed and relapsed or refractory disease are provided.
  • The author group encompasses a multidisciplinary group of experts from different institutions in Europe.

Recommendations are based on available scientific data and the authors’ collective expert opinion.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.